Leukocytosis Market Growth Forecast With Analysis Of Industry Progress Through 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Growth In Market Value Is Anticipated For The Leukocytosis Market Between 2026 And 2030?

The leukocytosis market has experienced robust growth in recent years. It is forecast to expand from $5.13 billion in 2025 to $5.41 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.4%. The historical expansion of this market can be linked to the widespread occurrence of infectious diseases, a rising incidence of inflammatory disorders, an increase in leukemia cases, the continued reliance on conventional blood tests, and the broadening of hospital-based diagnostic services.

The leukocytosis market size is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $6.63 billion, demonstrating a compound annual growth rate (CAGR) of 5.2%. Factors contributing to this growth during the forecast period include progress in hematology diagnostics, the increasing acceptance of personalized treatment methods, greater understanding of the importance of early disease detection, a rise in healthcare spending, and the broader implementation of laboratory automation. Key developments shaping the market during this period are the wider utilization of advanced blood diagnostics, a heightened emphasis on treatments targeting specific underlying diseases, the expanding application of precision medicine within hematology, the growth of automated and high-throughput testing capabilities, and the increasing incorporation of clinical decision support systems.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24278&type=smp

What Important Drivers Are Powering The Leukocytosis Market Growth?

The increasing occurrence of blood-related diseases is anticipated to stimulate the expansion of the leukocytosis market in the future. Blood-related diseases encompass medical conditions that impact blood components such as red blood cells, white blood cells, platelets, or plasma. The rise in these diseases is attributed to aging populations, as older individuals are more susceptible to ailments like anemia, leukemia, and clotting disorders due to a decline in immune function and cumulative health issues. Frequently, blood-related diseases result in elevated white blood cell counts, a definitive sign of leukocytosis, thereby emphasizing the demand for enhanced early diagnosis, improved monitoring instruments, and more effective therapeutic options. For instance, in 2024, the American Cancer Society, a US-based cancer organization, recorded 62,770 new cases of leukemia, marking a notable increase from 59,610 cases in 2023. Thus, the growing incidence of blood-related diseases is propelling the growth of the leukocytosis market.

What Are The Core Segment Classifications In The Leukocytosis Market?

The leukocytosis market covered in this report is segmented –

1) By Disease Type: Infection, Leukemia

2) By Diagnosis Type: Blood Tests, Bone Marrow Biopsy

3) By End User: Hospitals, Diagnostic Laboratories

Subsegments:

1) By Infection: Bacterial Infections, Viral Infections, Parasitic Infections, Fungal Infections

2) By Leukemia: Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia (ALL) with Hyperleukocytosis

Which Trends Are Expected To Shape The Leukocytosis Market?

Major companies in the leukocytosis market are increasingly focusing on incorporating artificial intelligence into diagnostic systems to advance early detection, enhance diagnostic accuracy, and refine personalized treatment planning. Artificial intelligence in diagnostic systems refers to the application of AI technologies such as machine learning, deep learning, and natural language processing to analyze medical data, thereby assisting in or automating the diagnosis of diseases. For instance, in December 2024, Koninklijke Philips NV, a Netherlands-based healthcare company, introduced the CT 5300 system. This system integrates proprietary artificial intelligence to improve computed tomography (CT) imaging workflows. It features the computed tomography smart workflow, which includes AI-driven tools like precise position, precise cardiac, and precise brain, designed to streamline scan preparation, heighten diagnostic accuracy, and lower radiation exposure.

Which Firms Are Competing In The Leukocytosis Market?

Major companies operating in the leukocytosis market are Pfizer Inc., Johnson & Johnson, Siemens Healthineers AG, Roche Diagnostics AG, Bristol Myers Squibb, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis International AG, Danaher Corporation, Merck KGaA, Becton Dickinson and Company (BD), Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics, Agilent Technologies Inc., Grifols SA, Hologic Inc., Illumina Inc., PerkinElmer Inc., Sysmex Corporation, Beckman Coulter Diagnostics Inc., Bio-Rad Laboratories, Bio-Techne Corporation, NeoGenomics Laboratories Inc., DiaSorin S.p.A.

Access The Complete Leukocytosis Market Report:

https://www.thebusinessresearchcompany.com/report/leukocytosis-global-market-report

Which Area Represents The Largest Portion Of The Leukocytosis Market?

North America was the largest region in the leukocytosis market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the leukocytosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Leukocytosis Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=24278&type=smp

Browse Through More Reports Similar to the Global Leukocytosis Market 2026, By The Business Research Company

Progressive Multifocal Leukoencephalopathy Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/progressive-multifocal-leukoencephalopathy-treatment-global-market-report

Pheochromocytoma Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pheochromocytoma-global-market-report

Leukotriene Modifiers Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/leukotriene-modifiers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795